Review Article
Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
Abstract
Androgenetic alopecia (AGA) is the most common form of hair loss in men, and female pattern hair loss (FPHL) is the most common form of hair loss in women. Traditional methods of treating hair loss have included minoxidil, finasteride, and surgical transplantation. Currently there is a myriad of new and experimental treatments. In addition, low-level light therapy (LLLT) has recently been approved by the United States Food and Drug Administration (FDA) for the treatment of hair loss. There are several theories and minimal clinical evidence of the safety and efficacy of LLLT, although most experts agree that it is safe. More in vitro studies are necessary to elucidate the mechanism and effectiveness at the cellular level, and more controlled studies are necessary to assess the role of this new treatment in the general population.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Bienová M, Kucerová R, Fiurásková M, et al. Androgenetic alopecia and current methods of treatment. Acta Dermatovenerol Alp Panonica Adriat 2005;14:5–8.
2. Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am 2007;36:379–398.
3. Poulos GA, Mirmirani P. Investigational medications in the treatment of alopecia. Expert Opin Investig Drugs 2005;14:177–184.
4. Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging 2007;2:189–199.
5. Stough D, Stenn K, Haber R, et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc 2005;80:1316–1322.
6. Shin HS, Won CH, Lee SH, et al. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial. Am J Clin Dermatol 2007;8:285–290.
7. Ellis JA, Sinclair RD. Male pattern baldness: current treatments, future prospects. Drug Discov Today 2008;13:791–797.
8. Price VH. Treatment of hair loss. N Engl J Med 1999;341:964–973.
9. Venkataram M. Changing trends in hair restoration surgery. Indian J Dermatol Venereol Leprol 2006;72:103–111; quiz 112, 125.
10. Scheinfeld N. A review of hormonal therapy for female pattern (androgenic) alopecia. Dermatol Online J 2008;14:1.
11. Haber RS. Pharmacologic management of pattern hair loss. Facial Plast Surg Clin North Am 2004;12:181–189.
12. Bedocs LA, Bruckner AL. Adolescent hair loss. Curr Opin Pediatr 2008;20:431–435.
13. Burkhart CG, Burkhart CN. 5 alpha-reductase and finasteride in pattern alopecia and acne. J Drugs Dermatol 2004;3:363–364.
14. Essah PA, Wickham EP III, Nunley JR, et al. Dermatology of androgen-related disorders. Clin Dermatol 2006;24:289–298.
15. Rogers GE, Hynd PI. Animal models and culture methods in the study of hair growth. Clin Dermatol 2001;19:105–119.
16. Wasserman D, Guzman-Sanchez DA, Scott K, et al. Alopecia areata. Int J Dermatol 2007;46:121–131.
17. Lenane P, Pope E, Krafchik B. Congenital alopecia areata. J Am Acad Dermatol 2005;52(2 suppl 1):8–11.
18. Dombrowski NC, Bergfeld WF. Alopecia areata: what to expect from current treatments. Cleve Clin J Med 2005;72:758, 760–751; 765–756 passim.
19. Ross EK, Shapiro J. Management of hair loss. Dermatol Clin 2005;23:227–243.
20. Bui K, Polisetty S, Gilchrist H, et al. Successful treatment of alopecia universalis with alefacept: a case report and review of the literature. Cutis 2008;81:431–434.
21. Buhl AE, Waldon DJ, Kawabe TT, et al. Minoxidil stimulates mouse vibrissae follicles in organ culture. J Invest Dermatol 1989;92:315–320.
22. Rawnsley JD. Hair restoration. Facial Plast Surg Clin North Am 2008;16:289–297, v.
23. Avram MR, Rogers NE. Hair transplantation for men. J Cosmet Laser Ther 2008;10:154–160.
24. Avram MR, Leonard RT Jr, Epstein ES, et al. The current role of laser/light sources in the treatment of male and female pattern hair loss. J Cosmet Laser Ther 2007;9:27–28.
25. Sobanko JF, Alster TS. Efficacy of low-level laser therapy for chronic cutaneous ulceration in humans: a review and discussion. Dermatol Surg 2008;34:991–1000.
26. Hamblin MR, Demidova TN. Mechanisms of low level light therapy Proc SPIE 2006;6140:1–12.
27. Desmet KD, Paz DA, Corry JJ, et al. Clinical and experimental applications of NIR-LED photobiomodulation. Photomed Laser Surg 2006;24:121–128.
28. Taub AF. Photodynamic therapy: other uses. Dermatol Clin. 2007;25:101–109.
29. Pastore D, Greco M, Petragallo VA, et al. Increase in ←H+/e- ratio of the cytochrome c oxidase reaction in mitochondria irradiated with helium-neon laser. Biochem Mol Biol Int 1994;34:817–826.
30. Yu W, Naim JO, McGowan M, et al. Photomodulation of oxidative metabolism and electron chain enzymes in rat liver mitochondria. Photochem Photobiol 1997;66:866–871.
31. Hawkins DH, Abrahamse H. The role of laser fluence in cell viability, proliferation, and membrane integrity of wounded human skin fibroblasts following helium-neon laser irradiation. Lasers Surg Med 2006;38:74–83.
32. Fernández-Guarino M, Harto A, García-Morales I, et al. Failure to treat alopecia areata with photodynamic therapy. Clin Exp Dermatol 2008;33:585–587.
33. Evans DH, Abrahamse H. Efficacy of three different laser wavelengths for in vitro wound healing. Photodermatol Photoimmunol Photomed 2008;24:199–210.
34. Haywood RM, Wardman P, Gault DT, et al. Ruby laser irradiation (694 nm) of human skin biopsies: assessment by electron spin resonance spectroscopy of free radical production and oxidative stress during laser depilation. Photochem Photobiol 1999;70:348–352.
35. Leavitt M, Charles G, Heyman E, et al. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig 2009;29:283–292.
36. Avram MR, Rogers NE. The use of low-level light for hair growth: part I. J Cosmet Laser Ther 2009;11:110–117.
37. Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci 1951;53:708–728.
38. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975;68:1359–1365.
